But Nathaniel Chin, associate professor at the University of Wisconsin-Madison Alzheimer’s Disease Research Center, said he was not surprised by the news, given other treatments coming to market.
But Nathaniel Chin, associate professor at the University of Wisconsin-Madison Alzheimer’s Disease Research Center, said he was not surprised by the news, given other treatments coming to market.